Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Are patients getting the "gist" in risk communication? Patient understanding of prognosis in breast cancer treatment.

Hutton DW, Belkora JK, Shachter RD, Moore DH.

J Cancer Educ. 2009;24(3):194-9. doi: 10.1080/08858190902876452.

PMID:
19526406
2.

Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.

Belkora JK, Rugo HS, Moore DH, Hutton DW, Chen DF, Esserman LJ.

BMC Cancer. 2009 Apr 28;9:127. doi: 10.1186/1471-2407-9-127.

3.

Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical?

Belkora J, Moore DH, Hutton DW.

Patient Educ Couns. 2009 Jul;76(1):106-12. doi: 10.1016/j.pec.2008.11.012. Epub 2009 Jan 1.

5.

Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis.

Robinson TM, Alexander SC, Hays M, Jeffreys AS, Olsen MK, Rodriguez KL, Pollak KI, Abernethy AP, Arnold R, Tulsky JA.

Support Care Cancer. 2008 Sep;16(9):1049-57. doi: 10.1007/s00520-007-0372-2. Epub 2008 Jan 15.

6.

Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication?

Belkora JK, Hutton DW, Moore DH, Siminoff LA.

J Natl Compr Canc Netw. 2011 Jul 1;9(7):707-12.

7.

Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS).

De Morgan SE, Butow PN, Lobb EA, Price MA, Nehill C.

Support Care Cancer. 2011 May;19(5):717-23. doi: 10.1007/s00520-010-1040-5. Epub 2010 Nov 19.

PMID:
21088858
8.

Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.

Siminoff LA, Graham GC, Gordon NH.

Patient Educ Couns. 2006 Sep;62(3):355-60. Epub 2006 Jul 24.

PMID:
16860520
9.

Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients.

Oskay-Ozcelik G, Lehmacher W, Könsgen D, Christ H, Kaufmann M, Lichtenegger W, Bamberg M, Wallwiener D, Overkamp F, Diedrich K, von Minckwitz G, Höffken K, Seeber S, Mirz R, Sehouli J.

Ann Oncol. 2007 Mar;18(3):479-84. Epub 2007 Feb 1.

PMID:
17272832
10.

Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.

Jacob Arriola KR, Mason TA, Bannon KA, Holmes C, Powell CL, Horne K, O'Regan R.

Patient Educ Couns. 2014 Apr;95(1):98-103. doi: 10.1016/j.pec.2013.12.019. Epub 2014 Jan 10.

PMID:
24492157
11.

Development of decision-support intervention for Black women with breast cancer.

Sheppard VB, Williams KP, Harrison TM, Jennings Y, Lucas W, Stephen J, Robinson D, Mandelblatt JS, Taylor KL.

Psychooncology. 2010 Jan;19(1):62-70. doi: 10.1002/pon.1530.

12.

Adjuvant chemotherapy for breast cancer patients: patients' expectations and physicians' attitudes.

Barak F, Ostrowsky LA, Kreitler S.

Palliat Support Care. 2012 Jun;10(2):107-14. doi: 10.1017/S1478951511000733. Epub 2012 Feb 24.

PMID:
22361448
13.

Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust.

Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H.

J Clin Oncol. 2009 Nov 1;27(31):5160-7. doi: 10.1200/JCO.2009.22.9773. Epub 2009 Sep 21.

14.

Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial.

Hack TF, Pickles T, Bultz BD, Ruether JD, Weir LM, Degner LF, Mackey JR.

J Clin Oncol. 2003 Nov 15;21(22):4138-44.

PMID:
14615442
15.

Discussing adjuvant cancer therapy.

Leighl N, Gattellari M, Butow P, Brown R, Tattersall MH.

J Clin Oncol. 2001 Mar 15;19(6):1768-78.

PMID:
11251008
16.

Breast cancer patients' experiences of patient-doctor communication: a working relationship.

McWilliam CL, Brown JB, Stewart M.

Patient Educ Couns. 2000 Feb;39(2-3):191-204.

PMID:
11040719
17.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

18.

Doctor-patient communication about breast cancer adjuvant therapy.

Siminoff LA, Fetting JH, Abeloff MD.

J Clin Oncol. 1989 Sep;7(9):1192-200.

PMID:
2671280
19.

Communication, breast cancer, and malpractice claims: a study.

Blades CE.

J Healthc Risk Manag. 1995 Fall;15(4):5-8. No abstract available.

PMID:
10151575
20.

Breast cancer, pregnancy, and breastfeeding.

Helewa M, Lévesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM; Breast Disease Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2002 Feb;24(2):164-80; quiz 181-4. English, French.

PMID:
12196882

Supplemental Content

Support Center